|
Volumn 21, Issue 12, 1998, Pages 1775-1778
|
Effect of ultrahigh-dose methylcobalamin on compound muscle action potentials in amyotrophic lateral sclerosis: A double-blind controlled study
a a a a a a a a |
Author keywords
Amyotrophic lateral sclerosis; Compound muscle action potentials; Methylcobalamin; Therapy
|
Indexed keywords
MECOBALAMIN;
ADULT;
AGED;
AMYOTROPHIC LATERAL SCLEROSIS;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG MEGADOSE;
FEMALE;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
MALE;
MUSCLE ACTION POTENTIAL;
MUSCLE ATROPHY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ACTION POTENTIALS;
ADULT;
AGED;
AMYOTROPHIC LATERAL SCLEROSIS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MUSCLE, SKELETAL;
TREATMENT OUTCOME;
VITAMIN B 12;
|
EID: 0031761315
PISSN: 0148639X
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-4598(199812)21:12<1775::AID-MUS22>3.0.CO;2-V Document Type: Article |
Times cited : (37)
|
References (8)
|